Orane Lorton1, Yacine M’Rad1, Pauline Coralie Guillemin1, Max Gau2, Pelagia Tsoutsou2, Thomas Zilli3, Pierre-Alexandre Poletti4, Rares Salomir1,4, and Sana Boudabbous1,5
1University of Geneva, Faculty of Medicine, Geneva, Switzerland, 2Radio-oncology department, University Hospitals of Geneva, Geneva, Switzerland, 3Radiation Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland, 4Radiology department, University Hospitals of Geneva, Geneva, Switzerland, 5University Hospitals of Geneva, Geneva, Switzerland
Synopsis
Keywords: MR-Guided Focused Ultrasound, Focused Ultrasound, Hyperthermia, focused ultrasound, bone metastasis
Motivation: Mild hyperthermia (HT) induced by magnetic resonance-guided focused ultrasound (MRgHIFU) before radiation therapy (RT) could act as adjuvant in pain relief for bone metastasis.
Goal(s): This study aims to evaluate the feasibility and safety of MRgHIFU procedure in one patient with a posterior right acetabulum
Approach: The target temperature elevation was 6°C. The targeting and temperature monitoring in near real-time were performed by MRI.
Results: The temperature elevation lasting 30-minutes was 6.01°C on average in bone metastasis. The MR-guidance allowed a safe and successful procedure without adverse events. The 25-minutes between HT end point and RT demonstrated the technical feasibility of the procedure.
Impact: This study is a first step to demonstrate MRgHIFU hyperthermia adjuvant
to palliative radiotherapy of bone metastases. The non-invasive, safe and
accurate use of focused ultrasound to sensitize tumors opens the way to more
efficient application of the radiation dose.
Introduction
Radiation
therapy (RT) is one of the most common palliative strategies in the treatment
of bone metastases. Several studies have demonstrated that inducing
hyperthermia before or after RT increases the effectiveness of the treatment.
Hyperthermia can be produced by radiofrequency waves, microwaves, lasers, or
high-intensity focused ultrasound (HIFU). HIFU has the advantage of being
non-invasive and can be guided in real-time by magnetic resonance (MRgHIFU). We
present the first case of a palliative treatment combining mild hyperthermia
induced by MRgHIFU and external beam radiation therapy (EBRT) in bone
metastases.Material and method
The trial was
approved by the national regulatory authorities and is registered with
clinicaltrials.gov. The patient signed a
written consent. The patient was a 48-year-old man suffering from multimetastatic
melanoma with mutated BRAF V600E and a multidisciplinary indication for a palliative
course of EBRT. The patient presented a large lytic mass in posterior right
acetabulum (4.8cm) associated with cortex discontinuity at 1.4cm of sciatic
nerve and 6.4cm of the skin. Karnofsky score was calculated at 60. The patient
lied in prone position on the MR table and the transducer was maintained posteriorly
in contact with the skin using a mechanical holder. The patient came for
simulation and targeting 5 days before the planned treatment to ensure the
technical feasibility and intra-operatory compliance with the procedure. The
simulation was used to plan the hyperthermia to save time on the day of the
intervention and to guarantee the timeline for RT.
Focused ultrasound was generated by an MR-compatible
phased array transducer operating at 650kHz dedicated to mild hyperthermia
(Imasonic, Voray-sur-l’Ognon, France). The natural focus of the transducer is
formed at 10-cm depth by 104 hexagonal-shaped elements. The variable sizes and
the asymmetric distribution of the element combined with the individual control
of each element allow the displacement of the focus in a volume of 10 x 20 x
30mm around the natural focus without the occurrence of significant secondary
lobes. The cooling and acoustic coupling were ensured by the circulation of approximately
1L of deionized and degassed water passing through a heat exchanger.
Targeting was performed using a 3D high-resolution
(HR) T1-weighted sequence acquired with a 12-element spine coil and a flexible 18-channel
coil in a 3T MR scanner (Prisma Fit, Siemens, Erlangen, Germany). The
parameters of this sequence were: FOV = 400 x 400mm2, TE = 1.32ms,
TR = 6ms, spatial resolution = 1.25 x 1.25 x 1.3m3, flip angle = 10°,
number of averages = 1. The temperature was monitored by the proton resonance
frequency shift (PRFS) method using a GRE-EPI sequence in 3 crossing planes
centered on the focus. The parameters of the thermometry sequence were: FOV =
256 x 256mm2, TE = 8.62ms, TR = 50ms, spatial resolution = 2 x 2 x
5m3, temporal resolution = 4.5s, flip angle = 15°, number of
averages = 1. MR images were reconstructed in real-time and magnitude images
were merged with temperature maps for near real-time temperature monitoring. At
the end of the sonication, the T1-weighted MR sequence used for targeting was
acquired again.
The target temperature elevation for mild hyperthermia
was 6°C for at least 30 minutes. The HIFU beam targeted the cortical break (Figure
1) to benefit from the acoustic oven effect [1], enhancing the spatial
homogeneity of the temperature. The delivered power ranging 19-39W was manually
adjusted by the interventional radiologist every 30 or 60 seconds with a 100%
duty cycle. A moving 15-point average filter was applied during post-processing
for noise reduction.
For the radiation therapy, the planning target volume
was delineated on a simulation scan and included the radiologically visible
bone metastasis with a 7-mm isotropic margin. Just after the hyperthermia, the
patient received a single 8 Gy fraction of palliative EBRT using a volumetric
modulated arc therapy (VMAT) technique.Results
The
simulation session lasted 120 minutes and the hyperthermia session lasted 90
minutes in total. The energy delivered in total was 105.6 kJ, for an average power
of 22.5W and a sonication duration of 30 minutes and 54 seconds. The time
interval between the end of the hyperthermia and the EBRT was 25 minutes. The
technical feasibility and workflow were demonstrated in this first patient. No pain
or adverse events were reported by the patient. The average temperature in the steady
state after was 6.01°C ± 0.38°C over a region of 1.8 x 1.4 x 1.2 cm3.Conclusion
We
report the first adjuvant hyperthermia induced by MRgHIFU before RT in one bone
metastasis. The intervention was safe, successful and without adverse events
which confirms its technical feasibility.Acknowledgements
No acknowledgement found.References
[1]
Guillemin PC, Gui L, Lorton O, Zilli T, Crowe LA,
Desgranges S, Montet X, Terraz S, Miralbell R, Salomir R, Boudabbous S. Mild
hyperthermia by MR-guided focused ultrasound in an ex vivo model of osteolytic
bone tumour: optimization of the spatio-temporal control of the delivered
temperature. J Transl Med. 2019 Oct 24;17(1):350.